| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/29/2003 | EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
| 10/29/2003 | EP1355629A1 Solid phase dispersion of quinolone- or naphthyridonecarboxylic acids |
| 10/29/2003 | EP1355628A2 Stabilised polymeric aerosols for pulmonary gene delivery |
| 10/29/2003 | EP1355626A2 Veterinary dermatologic composition |
| 10/29/2003 | EP1355588A2 Delivery of therapeutic capable agents |
| 10/29/2003 | EP1355566A2 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 10/29/2003 | EP1355542A2 Nutritional composition with health promoting action containing oligosaccharides |
| 10/29/2003 | EP1355541A1 Alpha-lactalbumin as prebiotic agent |
| 10/29/2003 | EP1355540A1 Food supplement with a slimming effect |
| 10/29/2003 | EP1257527B1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands |
| 10/29/2003 | EP1251853B1 Transdermal therapeutic system for the administration of zaleplon |
| 10/29/2003 | EP1239858B1 Pharmaceutical for the treatment of convulsive states |
| 10/29/2003 | EP1235787B1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 10/29/2003 | EP1214302B1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors |
| 10/29/2003 | EP1214056B1 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 10/29/2003 | EP1212324B1 Imidazo-triazine derivatives as ligands for gaba receptors |
| 10/29/2003 | EP1204663B1 Novel spiro compounds with neuropeptide y antagonistic activity |
| 10/29/2003 | EP1169316B9 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 10/29/2003 | EP1161230B1 Transdermal therapy system and method for producing the same |
| 10/29/2003 | EP1149092B1 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles |
| 10/29/2003 | EP1147112B1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 10/29/2003 | EP1140047B1 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs |
| 10/29/2003 | EP1107940B1 Vitamin d3 mimics |
| 10/29/2003 | EP1105096B1 Injectable aqueous dispersions of propofol |
| 10/29/2003 | EP1089964B1 Hydrazine derivatives |
| 10/29/2003 | EP1082129B1 Method for the treatment of fertility disorders |
| 10/29/2003 | EP1077935B1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| 10/29/2003 | EP1056705B1 Stable hyperforin salts, method for producing same and their use in the treatment of alzheimer's disease |
| 10/29/2003 | EP1032265B1 New psoralens for pathogen inactivation |
| 10/29/2003 | EP1024150B1 Process for producing cationic polymer |
| 10/29/2003 | EP1017370B1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs) |
| 10/29/2003 | EP1011692B1 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY |
| 10/29/2003 | EP1009451B1 Compositions and their use to prevent formation of adhesions in biological tissues |
| 10/29/2003 | EP1007527B1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same |
| 10/29/2003 | EP0994711B1 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function |
| 10/29/2003 | EP0983272B1 A new class of benzoporphyrin derivative photoactive compounds |
| 10/29/2003 | EP0971888B1 2-alkyl-19-nor-vitamin d compounds |
| 10/29/2003 | EP0970095B1 Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase |
| 10/29/2003 | EP0946162B1 Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases |
| 10/29/2003 | EP0941122B1 Compositions for polynucleotide delivery |
| 10/29/2003 | EP0923566B1 High molecular weight polymer-based prodrugs |
| 10/29/2003 | EP0922114B1 Catalytic nucleic acid and its medical use |
| 10/29/2003 | EP0921787B1 ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS |
| 10/29/2003 | EP0892632B1 Compositions useful in the phototherapeutic treatment of proliferative skin disorders |
| 10/29/2003 | EP0843663B9 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases |
| 10/29/2003 | EP0831822B1 The use of calcium channel antagonists for treating cardiac, renal and gastrointestinal disorders and hypertension |
| 10/29/2003 | EP0824347B1 Antiseptics for the ophtalmic mucous membrane containing magnesium perphthalate |
| 10/29/2003 | EP0779281B1 Isoxazoles |
| 10/29/2003 | EP0758240B1 Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections |
| 10/29/2003 | EP0732920B1 Therapeutic agents containing thyroid hormones |
| 10/29/2003 | EP0633881B1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
| 10/29/2003 | EP0594803B1 Composition for reducing side-effects of a drug |
| 10/29/2003 | CN1452657A Lubricated granules |
| 10/29/2003 | CN1452630A Substd. sapogenins and their use |
| 10/29/2003 | CN1452629A Skin tissue regeneration prmoters comprising ginsenoside Rb1 |
| 10/29/2003 | CN1452628A 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds |
| 10/29/2003 | CN1452627A 3'-prodrugs of 2'-deoxy-beta-L-nucleosides |
| 10/29/2003 | CN1452624A Hydropyridine deriv. acid addition salts |
| 10/29/2003 | CN1452623A 4-phenyl substd. tetrahydroisoquinolines and therapeutic use thereof |
| 10/29/2003 | CN1452622A Piperzine devivs. |
| 10/29/2003 | CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 10/29/2003 | CN1452619A Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 10/29/2003 | CN1452614A Arylpiperazine derivs. and their use as psychotropic agents |
| 10/29/2003 | CN1452613A Amorphous torasemide modification |
| 10/29/2003 | CN1452611A 13-substd. methacycline compounds |
| 10/29/2003 | CN1452610A Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system |
| 10/29/2003 | CN1452498A 药物活性化合物 Pharmaceutically active compounds |
| 10/29/2003 | CN1452497A Combinations of SSRI and estrogenic agents |
| 10/29/2003 | CN1452494A Use of secretin-receptorl igands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 10/29/2003 | CN1452490A Composition and method for intervening neuronal death using sulfasalazine |
| 10/29/2003 | CN1452489A Praziquantel composition for treating diseases due to sarcocystis, neospora, toxoplasma and isospora |
| 10/29/2003 | CN1452488A Treatment of inflammatory disorders |
| 10/29/2003 | CN1452487A Antimicrobial composition and mthod for producing same |
| 10/29/2003 | CN1452486A Pharmaceutical composition and use method |
| 10/29/2003 | CN1452485A Cannabinoid drugs |
| 10/29/2003 | CN1452484A Anthelmintics for preventing parasitic infections inhumans and animals |
| 10/29/2003 | CN1452483A IL-8 receptor antagonists |
| 10/29/2003 | CN1452482A Synergistic compositions contg. choline base and cuccinic acid for insulin resistance and diabetes |
| 10/29/2003 | CN1452480A Granular preparations for oral administration |
| 10/29/2003 | CN1452479A Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 10/29/2003 | CN1452461A Compositions and methods for body weight management |
| 10/29/2003 | CN1451665A Carboxylic derivs. of diosgenin and process for preparing same |
| 10/29/2003 | CN1451661A European verbena herb extract, and preparing process and use thereof |
| 10/29/2003 | CN1451656A Novel salt of perindopril and pharmaceutical composition contg. same |
| 10/29/2003 | CN1451438A Sparagin injection using xylitol as isosmotic adjusting agent |
| 10/29/2003 | CN1451424A Preparation of catechu suppository |
| 10/29/2003 | CN1451402A Chinese medicinal preparation for treating cadiovascular and cerebrovascular diseases |
| 10/29/2003 | CN1451390A Medicine use of cyclodextrin derivs. and medicine composition thereof |
| 10/29/2003 | CN1451389A Agent for promoting cell activation for external use |
| 10/29/2003 | CN1451388A Medicine for preventing and treating infectious diseases caused by virus, e.g. SARS |
| 10/29/2003 | CN1451387A Scutellaria root extract nose preparation |
| 10/29/2003 | CN1451386A Rifaximin soft capsule composition |
| 10/29/2003 | CN1451385A Oral compound hypoglycemic medicine |
| 10/29/2003 | CN1451384A Use of timosaponin for preparing medicine for preventing and treating brain apoplexy |
| 10/29/2003 | CN1451383A Use of albendazole sulfoxide and oxfendazole for preventing and treating fish parasite disease |
| 10/29/2003 | CN1451382A Medicine for treating senile dementia and preparing process thereof |
| 10/29/2003 | CN1451381A Process for preparing medicinal preparation contg. sulfonium methyl methionine chloride |
| 10/29/2003 | CN1451380A Percutaneous tobuterol patch |
| 10/29/2003 | CN1451379A Curcuma longa extract injection, and preparing process and use thereof |
| 10/29/2003 | CN1451378A ÔÇ£MaolansuÔÇØ fat emulsion as antineoplastic medicine and preparing process |